Clinical Practice

Low Back Pain Guidelines

Low Back Pain and Current Guidelines: What the Evidence Now Says

Low back pain is one of the most common reasons people seek physiotherapy, and one of the most frequently mismanaged. Clinical guidelines have shifted substantially over the past decade, away from imaging, bed rest, and passive treatment toward active management. What follows is a summary of where the evidence now stands and what it means

Low Back Pain and Current Guidelines: What the Evidence Now Says Read More »

Knee OA Management - PT Web

New Research in Knee OA Management: What the Evidence Says Now

Knee osteoarthritis affects a large proportion of patients in outpatient orthopedic practice. The research on conservative management has matured considerably over the past several years. Here is what the current evidence supports, what has been displaced, and the clinical takeaways most relevant to practice. Exercise Remains the Core Intervention The evidence for exercise in knee

New Research in Knee OA Management: What the Evidence Says Now Read More »

GLP-1 Drugs and Musculoskeletal Health for PTs

GLP-1 Medications and Musculoskeletal Health: What Physical Therapists Need to Know

GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are now among the most prescribed medications in the country. As more patients arrive in PT clinics on these drugs, clinicians need a working understanding of how they affect the musculoskeletal system. What Are GLP-1 Medications? GLP-1 (glucagon-like peptide-1) receptor agonists were originally developed

GLP-1 Medications and Musculoskeletal Health: What Physical Therapists Need to Know Read More »

Scroll to Top